GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Equity-to-Asset

Central Pharmaceutical JSC No2 (HSTC:DP2) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Central Pharmaceutical JSC No2's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Total Assets for the quarter that ended in . 20 was ₫0.00 Mil.

The historical rank and industry rank for Central Pharmaceutical JSC No2's Equity-to-Asset or its related term are showing as below:

HSTC:DP2's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Equity-to-Asset only.

Central Pharmaceutical JSC No2 Equity-to-Asset Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Equity-to-Asset Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Equity-to-Asset

Central Pharmaceutical JSC No2 Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Central Pharmaceutical JSC No2's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Equity-to-Asset falls into.



Central Pharmaceutical JSC No2 Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Central Pharmaceutical JSC No2's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Central Pharmaceutical JSC No2's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No2  (HSTC:DP2) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Central Pharmaceutical JSC No2 Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines